Daniel
De la Nava Martin
Investigador Colaborador
National Cancer Institute
Rockville, Estados UnidosNational Cancer Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
-
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393